-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Otd4k440NO6Py3X8C5sWTdrVjy+O7qZd8MeHK/6feYWG7T7FHWsXrNCtHDYBxj2o
 VPKpqV/BVOIIOzuIR+yyTg==

<SEC-DOCUMENT>0001186197-09-000003.txt : 20090616
<SEC-HEADER>0001186197-09-000003.hdr.sgml : 20090616
<ACCEPTANCE-DATETIME>20090616164629
ACCESSION NUMBER:		0001186197-09-000003
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		Rule 506
FILED AS OF DATE:		20090616
DATE AS OF CHANGE:		20090616
EFFECTIVENESS DATE:		20090616

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TRINITY BIOSYSTEMS INC
		CENTRAL INDEX KEY:			0001186197
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-47911
		FILM NUMBER:		09894392

	BUSINESS ADDRESS:	
		STREET 1:		1490 O'BRIEN AVENUE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		650-566-0780

	MAIL ADDRESS:	
		STREET 1:		1490 O'BRIEN AVENUE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0401</schemaVersion>

    <submissionType>D</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001186197</cik>
        <entityName>TRINITY BIOSYSTEMS INC</entityName>
        <issuerAddress>
            <street1>1490 O'BRIEN AVENUE</street1>
            <street2></street2>
            <city>MENLO PARK</city>
            <stateOrCountry>CA</stateOrCountry>
            <zipCode>94025</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>650-566-0780</issuerPhoneNumber>
        <issuerPreviousNameList>
            <value>None</value>
        </issuerPreviousNameList>
        <jurisdictionOfInc>DELAWARE</jurisdictionOfInc>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <overFiveYears>true</overFiveYears>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Amin</firstName>
                <middleName></middleName>
                <lastName>Khan</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Trinity Biosystems, Inc.</street1>
                <street2>1490 O'Brien Avenue</street2>
                <city>Menlo Park</city>
                <stateOrCountry>CA</stateOrCountry>
                <zipCode>94025</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Michael</firstName>
                <middleName>C.</middleName>
                <lastName>Diem</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o S.R. One Limited</street1>
                <street2>161 Washington St., Suite 500</street2>
                <city>Conshohocken</city>
                <stateOrCountry>PA</stateOrCountry>
                <zipCode>19428</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Rene</firstName>
                <middleName></middleName>
                <lastName>Kuijten</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Johannes Vermeerplein 9</street1>
                <street2></street2>
                <city>Amsterdam</city>
                <stateOrCountry>P7</stateOrCountry>
                <zipCode>1071 DV</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Peter</firstName>
                <middleName>C.</middleName>
                <lastName>McWilliams</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Sanderling Ventures</street1>
                <street2>400 S. El Camino Real, Suite 1200</street2>
                <city>San Mateo</city>
                <stateOrCountry>CA</stateOrCountry>
                <zipCode>94402</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>S.</firstName>
                <middleName>Edward</middleName>
                <lastName>Torres</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Lilly Ventures</street1>
                <street2>Lilly Corporate Center (DC 1032)</street2>
                <city>Indianapolis</city>
                <stateOrCountry>IN</stateOrCountry>
                <zipCode>46285</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Biotechnology</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>Decline to Disclose</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>false</isAmendment>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2009-05-15</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isDebtType>true</isDebtType>
            <isOptionToAcquireType>true</isOptionToAcquireType>
            <isSecurityToBeAcquiredType>true</isSecurityToBeAcquiredType>
            <isOtherType>true</isOtherType>
            <descriptionOfOtherType>Sale and issuance of Secured Convertible Promissory Notes convertible into Preferred Stock, the underlying shares of Common Stock issuable upon conversion of the Preferred Stock, and the issuance of Warrants exercsiable for Common Stock</descriptionOfOtherType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
            <clarificationOfResponse></clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>0</minimumInvestmentAccepted>
        <salesCompensationList></salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>12500000</totalOfferingAmount>
            <totalAmountSold>3365459</totalAmountSold>
            <totalRemaining>9134541</totalRemaining>
            <clarificationOfResponse></clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>14</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>0</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse></clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse></clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>TRINITY BIOSYSTEMS INC</issuerName>
                <signatureName>Danielle E. Reed</signatureName>
                <nameOfSigner>Danielle E. Reed</nameOfSigner>
                <signatureTitle>Secretary</signatureTitle>
                <signatureDate>2009-06-15</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----